| 摘要 |
<p>The present invention discloses a new polypeptide - human nerve growth factor 34, the polynucleotide encoding the same, as well as a method of producing said polypeptide by DNA recombinant techniques. The present invention also discloses methods of using the polypeptide in treatment of various diseases, such as malignant tumor, blood diseases, HIV infection, immunological diseases and a wide variety of inflammations. The invention also discloses an antagonist against the polypeptide and the therapeutic use thereof. Also disclosed is the use of such polynucleotide coding for the new human nerve growth factor 34.</p> |
